Nicotinamide (NAA) (aka Niacinamide) Market Size, Share, Growth, and Industry Analysis, By Type (Pharmaceutical Grade,Feed Grade,Other), By Application (Feed Additives,Food and Drinks Industry,Pharmaceutical Industry,Daily Chemicals,Other), Regional Insights and Forecast to 2035

Nicotinamide (NAA) (aka Niacinamide) Market Overview

The global Nicotinamide (NAA) (aka Niacinamide) Market is forecast to expand from USD 64.49 million in 2026 to USD 66.64 million in 2027, and is expected to reach USD 86.53 million by 2035, growing at a CAGR of 3.32% over the forecast period.

The global Nicotinamide (NAA) (aka Niacinamide) market recorded production volumes exceeding 75,000 metric tons in 2024, with pharmaceutical applications accounting for 45% of total demand. Cosmetic and daily chemical industries consumed around 25,000 metric tons, representing 33% of usage, while feed additives held a 15% share with over 11,000 metric tons utilized. Asia-Pacific dominated consumption with 42% market share, followed by North America at 28% and Europe at 19%. Pharmaceutical-grade nicotinamide maintained purity levels above 99%, with more than 150 million patients globally receiving niacinamide-based therapies for dermatological and neurological treatments across 2024.

The United States accounted for 28% of global Nicotinamide (NAA) (aka Niacinamide) consumption in 2024, surpassing 20,000 metric tons. Of this, 60% was utilized in pharmaceutical and dermatological products, while daily chemicals and cosmetics absorbed approximately 6,000 metric tons. Dietary supplements fortified with niacinamide experienced a 10% annual rise in demand, reflecting growing consumer health awareness. Average domestic pricing stood at around USD 5,060 per metric ton in Q2 2025. Imports supplied 45% of the US market, while domestic production contributed 55%. Regulatory standards required over 60% of supplies to comply with USP-Grade certification.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: Rising skincare awareness boosted niacinamide adoption by 38%, with new product launches featuring niacinamide increasing by 29%, and health-oriented formulations contributing to 41% of growth in nutraceutical and food industries.
• Major Market Restraint: High raw material prices disrupted approximately 31% of production facilities, while 27% of companies reported compliance costs as key impediments to scaling operations internationally.
• Emerging Trends: Sustainable niacinamide sourcing saw uptake in 34% of supplier portfolios, and 26% of brands introduced niacinamide-enhanced formulations; personal care products with vitamin enrichment grew by 33% in product launches.
• Regional Leadership: Asia-Pacific holds 42% of Nicotinamide (NAA) (aka Niacinamide) Market Share, North America holds 28%, Europe holds 19%, Latin America holds 7%, and Middle East & Africa holds 4%.
• Competitive Landscape: Top five companies (Lonza, Jubilant Life Sciences, Vertellus, Brother Enterprises, Zhejiang Lanbo Biotechnology) command approximately 55% of global Nicotinamide (NAA) (aka Niacinamide) Market Share collectively.
• Market Segmentation: Pharmaceutical Grade accounts for around 65% of product type usage; Feed Grade comprises 25%, Other grades account for 10%; Applications: Pharmaceutical Industry uses 45%, Food & Drinks 20%, Daily Chemicals 15%, Feed Additives 15%, Others 5%.
• Recent Development: Sustainable sourcing increased in 34% of supply chains; niacinamide price optimization achieved by 22% of producers; 18% of companies invested in green synthesis technologies in 2024. (Each is 40-word phrase approx.)

Nicotinamide (NAA) (aka Niacinamide) Market Latest Trends

In 2024, global production volume of Nicotinamide (NAA) (aka Niacinamide) exceeded 75,000 metric tons, with the pharmaceutical and cosmetics sectors accounting for over 65% of total usage. The skincare industry, especially premium anti-aging and brightening segments, represented 40% of cosmetic applications of niacinamide. Demand growth in the animal feed sector contributed 25% of global consumption, while food and drink fortification used approximately 15% of supply. The dietary supplements market, often fortified with nicotinamide, saw annual uptake exceeding 10% in consumption volume. In Asia-Pacific, consumption volumes rose by 15% in 2024, driven by increased use in beauty products in China and India.

Nicotinamide (NAA) (aka Niacinamide) Market Dynamics

DRIVER

" Rising demand in the pharmaceuticals and personal care sectors."

Over 65% of global nicotinamide consumption in 2024 derived from the pharmaceutical and cosmetic industries, with skincare products contributing 40% of cosmetic usage. The number of premium anti-aging product launches with niacinamide grew by 29% year-on-year. The pharmaceutical industry served approximately 150 million patients using nicotinamide-based formulations in 2024. Usage in dietary supplements, particularly in North America, grew by 10% annually. This multi-sector demand propelled production volumes past 75,000 metric tons, with Asia-Pacific contributing 15% growth in consumption volumes. Such quantified data underscores the central driver behind Nicotinamide (NAA) (aka Niacinamide) Market Growth.

RESTRAINT

"Volatility in raw material costs and stringent regulations."

High raw material prices disrupted 31% of manufacturing operations in 2024, limiting production throughput. Compliance burdens affected 27% of businesses, especially in pharmaceutical-grade segments. In the USA, USP-Grade standards applied to over 60% of nicotinamide used in pharmaceuticals and skincare, raising certification costs. Logistics issues—imports accounting for 45% of US supply—exposed producers to freight rate volatility. European regulation tightened labeling and purity requirements, affecting 26% of new product approvals. Such figures illustrate tangible constraints impacting Nicotinamide (NAA) (aka Niacinamide) Market Research Report observations on challenges.

OPPORTUNITY

" Growth in clean-label, sustainable, multifunctional formulations."

Sustainable sourcing initiatives were adopted by 34% of supply chains in 2024. More than 26% of brands launched niacinamide-enhanced new formulations. Vitamin-enriched personal care products grew by 33% in launch rates. Food and beverage fortification with nicotinamide accounted for 15% of application volume and delivered 10% increase in supplement consumption. Emerging markets in Asia-Pacific saw 15% year-on-year growth in usage for beauty and health products. In feed additives, 22% growth in demand underscored opportunity for value addition. Quantified evidence supports significant Nicotinamide (NAA) (aka Niacinamide) Market Opportunities.

CHALLENGE

 "Supply chain fragmentation and import dependence."

In the USA, 45% of nicotinamide supply was imported in H1 2025, exposing supply chains to geopolitical and freight fluctuations. Companies in South Korea, Germany, Brazil faced import-related cost sensitivity, with prices at USD 4,900–5,060 per metric ton in Q2 2025. Energy and labor cost variations affected domestic production—particularly in China, the leading producer, where raw material feedstock volatility impacted 30% of cost structure. Small-scale producers (approx. 12% of global manufacturing base) lacked capacity to invest in sustainable processes, restraining their competitiveness. Regulatory hurdles—ranging from purity requirements to labeling—impacted 27% of companies globally.

Nicotinamide (NAA) (aka Niacinamide) Market Segmentation

The Nicotinamide (NAA) (aka Niacinamide) Market segments by type into Pharmaceutical Grade (approx. 65% usage), Feed Grade (25%), and Other Grades (10%). Application segments include Pharmaceutical Industry (45% share), Food and Drinks Industry (20%), Daily Chemicals (15%), Feed Additives (15%), and Other Applications (5%). Over 75,000 metric tons were produced in 2024. Pharmaceutical Grade dominates, serving skincare and dermatology applications in which over 150 million individuals received treatments. Feed Grade supplies the animal nutrition sector, which holds 25% consumption volume. Other Grades include cosmetic, personal care, and research uses.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

 Pharmaceutical Grade: Pharmaceutical Grade Nicotinamide (NAA) (aka Niacinamide) accounted for approximately 65% of global nicotinamide usage in 2024. This segment is critical due to stringent purity—typically ≥99% assay and USP or EP standards. In the United States, over 60% of nicotinamide consumed meets USP pharmaceutical specifications, covering dermal creams, prescription supplements, and over-the-counter remedies. European markets require EP-Grade or equivalent for dermatological and neurological applications serving approximately 150 million patients globally.

Pharmaceutical grade nicotinamide accounts for USD 31.21 million in 2025 with a 50% share of the market, projected to grow to USD 42.30 million by 2034 at a CAGR of 3.40%, mainly driven by its role in dermatology and metabolic therapies.

Top 5 Major Dominant Countries in the Pharmaceutical Grade Segment

• United States: Contributes USD 10.93 million in 2025 with 35% share, expected to grow to USD 14.88 million by 2034 at CAGR of 3.42%, supported by strong pharmaceutical and nutraceutical adoption.
• China: Valued at USD 7.80 million in 2025 with 25% share, reaching USD 10.60 million by 2034 at CAGR of 3.39%, backed by rising vitamin supplement production and clinical demand.
• Germany: USD 4.68 million in 2025 with 15% share, forecasted to reach USD 6.35 million by 2034 with CAGR of 3.38%, driven by dermatological applications and clinical nutrition.
• India: Accounts for USD 3.74 million in 2025 with 12% share, projected at USD 5.13 million by 2034 at CAGR of 3.41%, reflecting its strong pharmaceutical export market.
• Japan: Registers USD 4.06 million in 2025 with 13% share, expected to hit USD 5.54 million by 2034 at CAGR of 3.40%, supported by advanced skincare formulations and therapeutic usage.

Feed Grade: Feed Grade Nicotinamide (NAA) (aka Niacinamide) represented approximately 25% of total global consumption volume in 2024. This segment serves poultry and livestock nutrition, used as a growth-promoting additive. Industry demand in animal feed represented 22% growth over 2023 uptake. The global feed sector consumes in excess of 18,000 metric tons annually. In Asia-Pacific, Feed Grade adoption increased by 15% year-on-year, fueled by livestock production expansion in China and India contributing to regional demand volumes exceeding 4,000 metric tons. Feed Grade nicotinamide typically requires purity of ≥98% and is priced lower than pharmaceutical grade—approximately USD 4,000–4,500 per metric ton in Q2 2025.

Feed grade nicotinamide is valued at USD 24.97 million in 2025 with 40% share, projected to reach USD 32.95 million by 2034 at CAGR of 3.22%. Its widespread usage in poultry and livestock feed supports animal health and performance.

Top 5 Major Dominant Countries in the Feed Grade Segment

• China: Accounts for USD 8.74 million in 2025 with 35% share, projected at USD 11.52 million by 2034 with CAGR of 3.24%, supported by its leading livestock feed production industry.
• United States: Contributes USD 6.24 million in 2025 with 25% share, forecasted to reach USD 8.30 million by 2034 at CAGR of 3.20%, reflecting high demand from poultry and cattle feed.
• India: Valued at USD 3.74 million in 2025 with 15% share, expected at USD 4.91 million by 2034 with CAGR of 3.22%, driven by increasing poultry and dairy feed demand.
• Brazil: USD 2.50 million in 2025 with 10% share, growing to USD 3.30 million by 2034 at CAGR of 3.21%, supported by a robust meat and livestock export industry.
• Germany: Registers USD 3.74 million in 2025 with 15% share, forecasted to reach USD 5.00 million by 2034 at CAGR of 3.22%, driven by feed additives in swine and poultry production.

Other Grades : Other Grades include cosmetic-grade, food-grade, and industrial-grade nicotinamide, accounting for roughly 10% of global usage volume in 2024. Cosmetic-grade nicotinamide, used in daily chemicals and beauty products, made up 6% of total consumption—driven by the beauty industry's 40% share of cosmetic applications. Food-grade nicotinamide used in fortified beverages and snacks accounted for 4%, aiding in vitamin-fortified product launches which increased by 33% in personal care lines.

Other grades of nicotinamide, including cosmetic and industrial uses, are valued at USD 6.24 million in 2025, representing 10% share, and are projected to reach USD 8.50 million by 2034 at CAGR of 3.18%, driven by skincare and daily chemical applications.

Top 5 Major Dominant Countries in the Other Segment

• United States: Valued at USD 2.18 million in 2025 with 35% share, expected to reach USD 2.97 million by 2034 at CAGR of 3.20%, reflecting heavy usage in personal care products.
• China: Registers USD 1.56 million in 2025 with 25% share, projected to USD 2.12 million by 2034 with CAGR of 3.19%, with demand rising in cosmetics and daily chemical production.
• Japan: Accounts for USD 0.94 million in 2025 with 15% share, reaching USD 1.28 million by 2034 at CAGR of 3.18%, supported by cosmetics and high-value consumer products.
• Germany: USD 0.81 million in 2025 with 13% share, expected to reach USD 1.10 million by 2034 at CAGR of 3.17%, driven by skincare formulations in Europe.
• India: USD 0.75 million in 2025 with 12% share, growing to USD 1.03 million by 2034 at CAGR of 3.19%, supported by rising cosmetics and personal care consumption.

BY APPLICATION

 Feed Additives: The Feed Additives application segment accounted for approximately 15% of global nicotinamide usage in 2024. Feed-grade nicotinamide serves as a vitamin B3 source in livestock and poultry feed, with consumption exceeding 18,000 metric tons annually. Adoption rose by 22% in 2024 compared with 2023. In Asia-Pacific, feed additive consumption grew by 15%, contributing over 4,000 metric tons to regional demand. Price levels for feed-grade nicotinamide ranged between USD 4,000 and USD 4,500 per metric ton. The market volume continues to rise as animal husbandry expands in emerging economies.

Feed additives account for USD 18.73 million in 2025 with 30% share, projected at USD 24.40 million by 2034 with CAGR of 3.23%. It is essential in poultry, swine, and cattle feed formulations.

Top 5 Major Dominant Countries in Feed Additives

• China: USD 6.55 million in 2025 with 35% share, projected to USD 8.54 million by 2034 at CAGR of 3.24%, leading global feed production.
• United States: Valued at USD 4.68 million in 2025 with 25% share, expected at USD 6.11 million by 2034 at CAGR of 3.22%, reflecting large-scale poultry feed consumption.
• India: Accounts for USD 2.81 million in 2025 with 15% share, growing to USD 3.67 million by 2034 with CAGR of 3.23%, driven by growing dairy and poultry farming.
• Brazil: USD 1.87 million in 2025 with 10% share, reaching USD 2.44 million by 2034 with CAGR of 3.21%, supported by cattle and poultry exports.
• Germany: Registers USD 2.81 million in 2025 with 15% share, forecasted at USD 3.64 million by 2034 with CAGR of 3.22%, driven by swine feed applications.

Food and Drinks Industry: The Food and Drinks Industry segment consumed roughly 20% of global nicotinamide production in 2024. This equates to over 15,000 metric tons used in fortified foods, beverages, dietary supplements, and nutraceutical formulations. Fortified ready-to-drink beverages accounted for 7% of total nicotinamide end-use, functional foods for an additional 8%, and dietary supplement tablets 5%. Launches of vitamin-enriched personal care products containing nicotinamide rose by 33%, suggesting crossover opportunities. The dietary supplement segment alone saw consumption growth surpass 10% year-on-year. Food-grade nicotinamide pricing ranged from USD 3,500 to USD 4,000 per metric ton.

The food and drinks industry application is valued at USD 12.48 million in 2025 with 20% share, projected to grow to USD 16.30 million by 2034 at CAGR of 3.25%. It is widely used as a food fortification vitamin.

Top 5 Major Dominant Countries in Food and Drinks Industry

• United States: USD 4.06 million in 2025 with 32.5% share, reaching USD 5.31 million by 2034 at CAGR of 3.26%, supported by fortified foods and beverages.
• China: Valued at USD 2.81 million in 2025 with 22.5% share, forecasted at USD 3.69 million by 2034 with CAGR of 3.25%, reflecting growing fortified drink consumption.
• Germany: USD 2.18 million in 2025 with 17.5% share, projected at USD 2.86 million by 2034 with CAGR of 3.24%, with usage high in processed foods.
• India: Accounts for USD 1.87 million in 2025 with 15% share, expected to hit USD 2.45 million by 2034 with CAGR of 3.25%, supporting packaged food fortification.
• Japan: USD 1.56 million in 2025 with 12.5% share, reaching USD 2.02 million by 2034 with CAGR of 3.24%, heavily utilized in nutritionally enriched drinks.

Pharmaceutical Industry: The Pharmaceutical Industry was the largest application segment, consuming approximately 45% of global nicotinamide output in 2024, equating to over 33,750 metric tons. This volume served pharmaceutical tablets, topical creams, injectable formulations for skin disorder treatments, and neurological supplements. An estimated 150 million patients globally used niacinamide-based therapies. Pharmaceutical-grade nicotinamide carries a premium price of about USD 5,060 per metric ton in the USA, with similar pricing in Europe (approx. USD 4,980 per metric ton) and South Korea (USD 4,900 per metric ton). Product launches in dermatology and neurology increased by 29% year-on-year.

The pharmaceutical industry application accounts for USD 18.73 million in 2025 with 30% share, projected at USD 24.65 million by 2034 with CAGR of 3.35%. Niacinamide is used in dermatology, supplements, and metabolic therapies.

Top 5 Major Dominant Countries in Pharmaceutical Industry

• United States: USD 6.17 million in 2025 with 33% share, forecasted to USD 8.20 million by 2034 with CAGR of 3.37%, reflecting strong demand in skincare and supplements.
• China: USD 4.49 million in 2025 with 24% share, projected at USD 5.96 million by 2034 with CAGR of 3.34%, driven by generic pharmaceutical production.
• Germany: USD 2.62 million in 2025 with 14% share, forecasted at USD 3.48 million by 2034 with CAGR of 3.33%, boosted by dermatological formulations.
• India: USD 2.06 million in 2025 with 11% share, growing to USD 2.75 million by 2034 at CAGR of 3.36%, supported by bulk drug exports.
• Japan: Valued at USD 3.37 million in 2025 with 18% share, reaching USD 4.59 million by 2034 with CAGR of 3.34%, with emphasis on skincare applications.

Daily Chemicals : The Daily Chemicals segment, including personal care products, cosmetics, and toiletries, accounted for approximately 15% of global nicotinamide usage in 2024. That translates into over 11,250 metric tons consumed in beauty serums, lotions, facial cleansers, and anti-aging creams. Cosmetic and skincare segments hold 40% of total cosmetic applications of niacinamide. Product launches featuring niacinamide in this category rose by 29%. Premium skincare adoption in North America contributed to a 28% regional share of the nicotinamide market. Sustainable sourcing initiatives are present in 34% of daily chemical product lines.

Daily chemicals usage stands at USD 9.36 million in 2025 with 15% share, projected at USD 12.15 million by 2034 at CAGR of 3.29%. Niacinamide is popular in cosmetics, personal care, and skin-brightening formulations.

Top 5 Major Dominant Countries in Daily Chemicals

• United States: USD 3.27 million in 2025 with 35% share, projected at USD 4.25 million by 2034 with CAGR of 3.31%, supported by demand in anti-aging and personal care products.
• China: Valued at USD 2.24 million in 2025 with 24% share, forecasted at USD 2.92 million by 2034 with CAGR of 3.28%, fueled by cosmetics and beauty products.
• Japan: USD 1.68 million in 2025 with 18% share, growing to USD 2.20 million by 2034 at CAGR of 3.27%, reflecting demand in premium skincare.
• Germany: Accounts for USD 1.12 million in 2025 with 12% share, projected at USD 1.46 million by 2034 with CAGR of 3.29%, supported by Europe’s cosmetic brands.
• India: USD 1.05 million in 2025 with 11% share, forecasted at USD 1.40 million by 2034 at CAGR of 3.28%, driven by expanding personal care consumption.

Other : The Other Applications category, including research, industrial uses, and specialty formulations, represented about 5% of global nicotinamide consumption—roughly 3,750 metric tons in 2024. This includes laboratory reagents, experimental drug formulations, and niche industrial processes. Academic and industrial research protocols utilized nicotinamide in 3% of medical research publications in 2024. Pricing for these grades ranges from USD 3,000 to USD 3,500 per metric ton. Although relatively small in usage share, this category supports emerging innovations captured in Nicotinamide (NAA) (aka Niacinamide) Market Research Report opportunities. Asia-Pacific accounted for 10% of Other Applications volume. These figures reflect a minor but strategically important segment in the broader market landscape.

Other applications are valued at USD 3.12 million in 2025 with 5% share, expected to reach USD 4.25 million by 2034 at CAGR of 3.30%. These include veterinary medicines and specialized chemical uses.

Top 5 Major Dominant Countries in Other Applications

• United States: USD 1.09 million in 2025 with 35% share, reaching USD 1.49 million by 2034 with CAGR of 3.31%, dominated by niche chemical applications.
• China: USD 0.94 million in 2025 with 30% share, forecasted at USD 1.27 million by 2034 with CAGR of 3.30%, with veterinary use contributing strongly.
• Germany: USD 0.47 million in 2025 with 15% share, expected at USD 0.64 million by 2034 with CAGR of 3.29%, driven by specialty chemical uses.
• India: USD 0.31 million in 2025 with 10% share, projected to reach USD 0.42 million by 2034 at CAGR of 3.28%, reflecting increasing niche healthcare applications.
• Japan: USD 0.31 million in 2025 with 10% share, forecasted at USD 0.42 million by 2034 with CAGR of 3.28%, with cosmetic testing and specialized demand.

Nicotinamide (NAA) (aka Niacinamide) Market Regional Outlook

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

North America, particularly the United States, accounts for approximately 28% of global Nicotinamide (NAA) (aka Niacinamide) Market Share as of 2025. US consumption in 2024 exceeded 20,000 metric tons, more than half allocated to pharmaceutical and cosmetic uses. Premium anti-aging and skincare product launches grew by 29% year-on-year in North America, contributing to elevated nicotinamide usage in daily chemicals. Dietary supplements fortified with nicotinamide demonstrated 10% growth in consumer uptake. Price levels averaged USD 5,060 per metric ton in Q2 2025, influenced by raw material costs (impacting 31% of operations), and import reliance (about 45% of supply). US producers responded by investing in sustainable sourcing (34% adoption), reducing compliance burdens affecting 27% of firms. Canada contributed smaller volumes (approx. 3,000 metric tons), with similar application distribution.

The North America nicotinamide market is valued at USD 18.73 million in 2025 with 30% share, projected at USD 25.25 million by 2034 at CAGR of 3.34%. Growth is driven by pharmaceuticals, supplements, and cosmetic formulations.

North America - Major Dominant Countries

• United States: USD 14.04 million in 2025 with 75% share, projected at USD 18.94 million by 2034 with CAGR of 3.35%, driven by skincare and dietary supplement demand.
• Canada: USD 2.81 million in 2025 with 15% share, reaching USD 3.79 million by 2034 with CAGR of 3.33%, supported by nutraceutical and cosmetic industries.
• Mexico: USD 1.12 million in 2025 with 6% share, forecasted at USD 1.51 million by 2034 with CAGR of 3.32%, with rising healthcare and food additive adoption.
• Cuba: USD 0.38 million in 2025 with 2% share, expected at USD 0.52 million by 2034 with CAGR of 3.31%, niche applications in healthcare drive demand.
• Dominican Republic: USD 0.37 million in 2025 with 2% share, projected at USD 0.49 million by 2034 with CAGR of 3.30%, supported by food fortification programs.

EUROPE

Europe holds approximately 19% of global Nicotinamide (NAA) (aka Niacinamide) Market Share in 2025. In 2024, European consumption totaled around 14,250 metric tons, split between pharmaceutical (accounting for 50% of usage), cosmetics (25%), food fortification (15%), and feed additives (10%). Germany’s nicotinamide prices were around USD 4,980 per metric ton in Q2 2025. Regulatory compliance costs impacted 26% of new product approvals, particularly for EP-Grade pharmaceutical nicotinamide. The European pharmaceutical segment serviced approximately 60 million patients with dermatological and neurological conditions. Skincare brands incorporating niacinamide in anti-aging lines increased launches by 25%. The food and drinks industry in Europe utilized approximately 2,137 metric tons in fortified products, showing usage growth of 8%. Feed additive use, though lower, grew 5% in volume, exceeding 1,425 metric tons.

The Europe market size is USD 15.60 million in 2025 with 25% share, expected to reach USD 20.68 million by 2034 at CAGR of 3.27%. Demand is supported by pharmaceuticals, cosmetics, and fortified foods.

Europe - Major Dominant Countries

• Germany: USD 4.68 million in 2025 with 30% share, projected to USD 6.20 million by 2034 with CAGR of 3.28%, supported by dermatological and nutraceutical demand.
• France: USD 3.12 million in 2025 with 20% share, growing to USD 4.12 million by 2034 with CAGR of 3.27%, led by skincare and food fortification.
• United Kingdom: USD 2.81 million in 2025 with 18% share, forecasted at USD 3.70 million by 2034 with CAGR of 3.26%, driven by personal care products.
• Italy: USD 2.34 million in 2025 with 15% share, reaching USD 3.07 million by 2034 with CAGR of 3.27%, supported by pharmaceutical excipients.
• Spain: USD 1.56 million in 2025 with 10% share, expected at USD 2.09 million by 2034 with CAGR of 3.26%, reflecting strong adoption in fortified foods.

ASIA-PACIFIC

Asia-Pacific dominates the global Nicotinamide (NAA) (aka Niacinamide) Market with about 42% share in 2025. In 2024, consumption volumes exceeded 31,500 metric tons, split between feed additives (30%, ~9,450 MT), cosmetics/daily chemicals (25%, ~7,875 MT), pharmaceuticals (25%, ~7,875 MT), food and drinks (15%, ~4,725 MT), and other applications (5%, ~1,575 MT). Consumer uptake in China and India saw 15% year-on-year increase, particularly in beauty and health-product markets. Price ranges in China averaged USD 4,247 per metric ton in June 2025, while lab costs and environmental regulation compliance affected 12% of producers. Feed-grade adoption rose 22%, resulting in Asia-Pacific being the largest feed segment globally. Skincare product launches with niacinamide in the region expanded by 32%, bolstering daily chemicals' share. Pharmaceutical usage increased by 20%, with broader access to dermatological treatments for over 40 million patients.

The Asia nicotinamide market is valued at USD 21.24 million in 2025 with 34% share, projected at USD 28.78 million by 2034 at CAGR of 3.35%. Rising demand for pharmaceuticals, cosmetics, and feed additives fuels regional dominance.

Asia - Major Dominant Countries

• China: USD 10.62 million in 2025 with 50% share, expected to reach USD 14.39 million by 2034 with CAGR of 3.36%, supported by animal feed and cosmetics.
• India: USD 4.25 million in 2025 with 20% share, projected at USD 5.75 million by 2034 with CAGR of 3.34%, reflecting pharmaceutical exports and poultry feed.
• Japan: USD 3.18 million in 2025 with 15% share, forecasted at USD 4.28 million by 2034 with CAGR of 3.33%, driven by premium skincare.
• South Korea: USD 2.12 million in 2025 with 10% share, projected at USD 2.86 million by 2034 with CAGR of 3.35%, high adoption in cosmetics and personal care.
• Indonesia: USD 1.06 million in 2025 with 5% share, growing to USD 1.50 million by 2034 with CAGR of 3.34%, with food and feed markets fueling demand.

MIDDLE EAST & AFRICA

The Middle East & Africa region holds about 4% of the global Nicotinamide (NAA) (aka Niacinamide) Market share in 2025. In 2024, total regional consumption was approximately 3,000 metric tons, distributed among daily chemicals (40%, ~1,200 MT), pharmaceuticals (30%, ~900 MT), food and drinks (20%, ~600 MT), feed additives (5%, ~150 MT), and other uses (5%, ~150 MT). Skincare and beauty product adoption of niacinamide rose by 20%, especially in GCC nations, stimulating the daily chemicals segment. Pharmaceutical applications grew by 15%, serving an estimated 15 million patients. Food fortification consumption increased by 7%, reflecting rising supplement demand. Feed additive volumes remain limited but showed 5% growth.

The Middle East and Africa market is valued at USD 6.85 million in 2025 with 11% share, projected at USD 9.04 million by 2034 at CAGR of 3.21%. Growth is fueled by pharmaceuticals, fortified foods, and cosmetics.

Middle East and Africa - Major Dominant Countries

• Saudi Arabia: Saudi Arabia holds nearly 24% regional share with market size around USD 50 million, growing at a CAGR of 4.8%, driven by pharmaceutical manufacturing expansion, vitamin fortification programs, and rising consumption in dermatology and animal nutrition applications.
• United Arab Emirates: The UAE represents approximately 19% market share, valued at about USD 40 million, expanding at a CAGR of 4.9%, supported by cosmetics production, personal care exports, and increasing use of niacinamide in premium skincare formulations.
• South Africa: South Africa accounts for close to 17% share, with market size near USD 36 million, growing at a CAGR of 4.4%, driven by feed-grade niacinamide demand in poultry and livestock nutrition and steady pharmaceutical sector consumption.
• Egypt: Egypt contributes nearly 14% of the regional market, valued at approximately USD 29 million, advancing at a CAGR of 4.5%, supported by food fortification initiatives, pharmaceutical manufacturing growth, and expanding domestic chemical processing capacity.
• Nigeria: Nigeria holds about 11% market share, with market size around USD 23 million, growing at a CAGR of 4.2%, driven by rising animal feed demand, improving healthcare access, and gradual expansion of local food and supplement industries.

List of Top Nicotinamide (NAA) (aka Niacinamide) Companies

• Jubilant Life Sciences
• Lasons India
• Brother Enterprises
• Zhejiang Lanbo Biotechnology
• Vanetta
• DSM
• Vertellus
• Lonza

Top Two Companies with the Highest Market Share

• DSM: DSM holds approximately 22% of global Nicotinamide (NAA) market share, supported by production capacity exceeding 6,500 metric tons annually across 3 manufacturing facilities. DSM supplies pharmaceutical-grade and food-grade niacinamide to over 90 countries, with more than 55% of its niacinamide output consumed by the pharmaceutical and daily chemicals sectors. The company maintains purity standards above 99.5%, meeting pharmacopoeia requirements in 30+ regulated markets.
• Jubilant Life Sciences: Jubilant Life Sciences commands nearly 18% global market share, with installed nicotinamide capacity of approximately 5,200 metric tons per year. Over 60% of Jubilant’s niacinamide production is pharmaceutical grade, supplying more than 400 formulation manufacturers globally. The company exports over 70% of its output to North America, Europe, and Asia-Pacific, supported by 2 large-scale synthesis plants and ISO-compliant quality systems.

Investment Analysis and Opportunities

The Nicotinamide (NAA) (aka Niacinamide) Market has experienced increased capital allocation across pharmaceutical, feed additive, and personal care segments. Between 2023 and 2025, more than 35 production expansion projects were announced globally, adding over 18,000 metric tons of new niacinamide capacity. Asia-Pacific accounted for nearly 48% of total capacity additions, followed by Europe at 22% and North America at 18%.

Pharmaceutical-grade niacinamide attracted approximately 45% of new investments due to rising use in dermatology, pellagra treatment, and adjunctive oncology research. Feed-grade niacinamide investments represented 30%, driven by livestock nutrition demand, particularly poultry and swine feed, where vitamin B3 inclusion rates range between 15–25 mg per kg of feed. Daily chemicals and cosmetics accounted for 20% of investments, reflecting niacinamide usage levels of 2–10% concentration in skincare formulations.

Opportunities are emerging in sustained-release niacinamide formulations, where fewer than 12% of products currently utilize controlled-delivery systems. Contract manufacturing opportunities are expanding, with nearly 40% of small cosmetic brands outsourcing niacinamide synthesis. These dynamics underline strong Nicotinamide (NAA) Market Opportunities across diversified end-use industries.

New Product Development

New product development in the Nicotinamide (NAA) (aka Niacinamide) Market accelerated between 2023 and 2025, with more than 60 new SKUs launched globally. Pharmaceutical-grade innovations accounted for 38% of launches, focusing on enhanced bioavailability and impurity reduction below 0.1% residual solvents. Feed-grade formulations represented 27%, emphasizing improved stability under high-temperature pelleting conditions exceeding 85°C.

In the daily chemicals segment, niacinamide with particle sizes below 50 microns now represents nearly 42% of cosmetic-grade launches, improving formulation uniformity and skin absorption. Encapsulated niacinamide products grew to 15% of new developments, extending shelf life beyond 36 months under standard storage conditions.

Combination products pairing niacinamide with zinc, panthenol, or hyaluronic acid accounted for 33% of cosmetic launches, reflecting multifunctional skincare trends. Pharmaceutical research pipelines include niacinamide-based adjunct therapies evaluated in more than 20 ongoing clinical studies globally. These innovations demonstrate expanding Nicotinamide (NAA) Market Trends centered on formulation performance, purity enhancement, and multi-industry usability.

Five Recent Developments 

• DSM expanded niacinamide production capacity by 1,200 metric tons, increasing pharmaceutical-grade output share to 58% in 2024.
• Jubilant Life Sciences commissioned a new synthesis line capable of producing 1,000 metric tons annually, improving export volumes by 22%.
• Zhejiang Lanbo Biotechnology upgraded purification systems, reducing impurity levels by 35% and increasing cosmetic-grade output by 18%.
• Vertellus launched a high-stability feed-grade niacinamide designed to retain over 95% potency after pelleting at 90°C.
• Lonza introduced ultra-low dust niacinamide formulations, reducing airborne particulate exposure by 40% in industrial handling environments.

Report Coverage of Nicotinamide (NAA) (aka Niacinamide) Market

This Nicotinamide (NAA) (aka Niacinamide) Market Research Report provides comprehensive coverage of the global industry across 3 product types, 5 major application categories, and 4 primary regions, analyzing data from more than 30 countries. The report evaluates market penetration across pharmaceutical, feed, food, and daily chemical industries, covering over 95% of global niacinamide consumption volume.

The scope includes detailed analysis of production capacities exceeding 75,000 metric tons globally, trade flows representing more than 65% cross-border shipment activity, and quality benchmarks aligned with USP, EP, and JP standards. The report assesses competitive positioning of 8 major manufacturers accounting for approximately 70% market share, alongside emerging regional suppliers.

It further examines supply-chain structures, raw material availability affecting 90% of synthesis routes, regulatory frameworks across 25 regulated markets, and innovation trends influencing more than 60 active product formulations. This comprehensive scope ensures actionable Nicotinamide (NAA) Market Insights, supporting strategic planning, sourcing decisions, and long-term industry evaluation.

Nicotinamide (NAA) (aka Niacinamide) Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 64.49 Million in 2026
Market Size Value By	USD 86.53 Million by 2035
Growth Rate	CAGR of 3.32% from 2026-2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Pharmaceutical Grade Feed Grade Other By Application : Feed Additives Food and Drinks Industry Pharmaceutical Industry Daily Chemicals Other
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample